Cargando…

32.1 MECHANISMS OF ABNORMAL POSTTRANSLATIONAL PROTEIN PROCESSING IN SCHIZOPHRENIA BRAIN

BACKGROUND: Molecular disturbances of neurotransmitter systems have long been held to be a core feature of the pathophysiology of schizophrenia. Despite years of study of neurotransmitter associated protein expression at multiple levels of gene expression, reports of abnormal neurotransmitter recept...

Descripción completa

Detalles Bibliográficos
Autor principal:	Meador-Woodruff, James
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888216/ http://dx.doi.org/10.1093/schbul/sby014.132

Ejemplares similares

F202. ABNORMAL REMODELING PROCESSING IN NEURAL GPI-APS SECRETORY PATHWAY IN SCHIZOPHRENIA
por: Kim, Pitna, et al.
Publicado: (2018)

Reviewers BJCVS 32.1
Publicado: (2017)

S192. AKT-MTOR SIGNALING PATHWAY IS DOWNREGULATED IN SCHIZOPHRENIA
por: Chadha, Radhika, et al.
Publicado: (2018)

32.2 ABNORMALITIES OF SYNAPTIC PROTEOMES IN SCHIZOPHRENIA
por: Funk, Adam, et al.
Publicado: (2018)

F199. O-GLCNAC DYSREGULATION IN SCHIZOPHRENIA CORTEX
por: Mueller, Toni, et al.
Publicado: (2018)

Abnormal ER quality control of neural GPI-anchored proteins via dysfunction in ER export processing in the frontal cortex of elderly subjects with schizophrenia
por: Kim, Pitna, et al.
Publicado: (2019)

Abnormal subcellular localization of GABA(A) receptor subunits in schizophrenia brain
por: Mueller, T M, et al.
Publicado: (2015)

Glutamate Receptor Abnormalities in Schizophrenia: Implications for Innovative Treatments
por: Rubio, Maria D., et al.
Publicado: (2012)

32.3 MAGNIFYING THE PROTEOME OF SCHIZOPHRENIA BRAINS
por: Fioramonte, Mariana, et al.
Publicado: (2018)

Synthesis and Characterization of an Analgesic Potential Conotoxin Lv32.1
por: Liu, Siyi, et al.
Publicado: (2022)

Post-translational protein modifications in schizophrenia
por: Mueller, Toni M., et al.
Publicado: (2020)

T181. PROTEIN ACYL-THIOESTERASE ENZYME ACTIVITY IN THE POSTMORTEM DORSOLATERAL PREFRONTAL CORTEX IN SCHIZOPHRENIA
por: Hopper, Shaun, et al.
Publicado: (2020)

S32.1 H5N1 and SARS — What have we learned?
Publicado: (2005)

32.1 The Impact of COVID-19 on the Mental Health of Black Youth and Available Resources
por: Onyejiaka, Chioma A.
Publicado: (2022)

32. DIGGING DEEPER IN THE PROTEOME OF SCHIZOPHRENIA
por: Martins-De-Souza, Daniel
Publicado: (2018)

Abnormalities of signal transduction networks in chronic schizophrenia
por: McGuire, Jennifer L., et al.
Publicado: (2017)

Intracellular compartment-specific proteasome dysfunction in postmortem cortex in schizophrenia subjects
por: Scott, Madeline R., et al.
Publicado: (2019)

K- p Elastic scattering at 32.1 GeV/c and analysis in the impact parameter representation
por: Bogolyubsky, M Yu, et al.
Publicado: (1981)

321. Assessing the Role of Daptomycin as Antibiotic Therapy for Staphylococcal Prosthetic Joint Infection
por: Miller, Andy, et al.
Publicado: (2018)

PM321. DNA Methylation Signature Associated with Abstinence in Alcoholics Treated with Acamprosate
por: Hlady, R., et al.
Publicado: (2016)

Protein expression of prenyltransferase subunits in postmortem schizophrenia dorsolateral prefrontal cortex
por: Pinner, Anita L., et al.
Publicado: (2020)

S11. BRAIN ABNORMALITIES ASSOCIATED WITH DISEASE-SPECIFIC AND GENETIC RISK FACTORS FOR SCHIZOPHRENIA
por: Goghari, Vina
Publicado: (2018)

K+p, K-p and $\overline{p}$p elastic scattering at 32.1 GeV/c
por: Lewin, C, et al.
Publicado: (1979)

Genome-wide association study identifies locus at chromosome 2q32.1 associated with syncope and collapse
por: Hadji-Turdeghal, Katra, et al.
Publicado: (2020)

321. Early Intervention: Readmission Reduction Efforts in OPAT via Early Patient Contact
por: Swartwood, Michael, et al.
Publicado: (2023)

321. Clinical Characteristics of Hospitalized HIV Patients with COVID-19 in Miami
por: Ayoade, Folusakin, et al.
Publicado: (2021)

Posttranslational regulation of the bile salt export pump
por: Przybylla, Susanne, et al.
Publicado: (2014)

Posttranslational Chemical Mutagenesis Methods to Insert Posttranslational Modifications into Recombinant Proteins
por: Harel, Omer, et al.
Publicado: (2022)

A novel chromosome 2q24.3‐q32.1 microdeletion in a fetus with multiple malformations
por: Zhu, Mianmian, et al.
Publicado: (2022)

3.2 PARVALBUMIN INTERNEURON IMPAIRMENT INDUCED BY OXIDATIVE STRESS AS A COMMON PATHOLOGICAL MECHANISM IN ANIMAL MODELS OF SCHIZOPHRENIA
por: Cabungcal, Jan Harry, et al.
Publicado: (2018)

De Novo Interstitial Microdeletion at 1q32.1 in a 10-Year-Old Boy with Developmental Delay and Dysmorphism
por: Carter, Jennifer, et al.
Publicado: (2016)

Posttranslational Modifications of Rev-Erbα Protein and Abnormal Inflammatory Response in Gastric Cancer
por: Ke, Chen, et al.
Publicado: (2022)

Posttranslational Processing and Modification of Cathepsins and Cystatins
por: Katunuma, Nobuhiko
Publicado: (2010)

Molecular diagnosis of cytogenetic abnormalities in patients with schizophrenia
por: Bar Shai, M., et al.
Publicado: (2022)

The Degradation Pathway of the Mitophagy Receptor Atg32 Is Re-Routed by a Posttranslational Modification
por: Levchenko, Mariia, et al.
Publicado: (2016)

Actin polymerization is reduced in the anterior cingulate cortex of elderly patients with schizophrenia
por: Bhambhvani, Hriday P., et al.
Publicado: (2017)

A new mosaic der(18)t(1;18)(q32.1;q21.3) with developmental delay and facial dysmorphism
por: Choi, Young-Jin, et al.
Publicado: (2016)

Structural variations in a non-coding region at 1q32.1 are responsible for the NYS7 locus in two large families
por: Sun, Wenmin, et al.
Publicado: (2020)

Posttranslational modification of proteins : expanding nature's inventory /
por: Walsh, Christopher
Publicado: (2006)

Altered distribution and localization of organellar Na(+)/H(+) exchangers in postmortem schizophrenia dorsolateral prefrontal cortex
por: Pruett, Brandon S., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9skqrd6ojdtn6drb77mfmff2eq